Jan Marini Skin Research Revenue and Competitors
Estimated Revenue & Valuation
- Jan Marini Skin Research's estimated annual revenue is currently $15M per year.
- Jan Marini Skin Research's estimated revenue per employee is $68,182
Employee Data
- Jan Marini Skin Research has 220 Employees.
- Jan Marini Skin Research grew their employee count by 7% last year.
Jan Marini Skin Research's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | VP, R&D/Quality/Regulatory | Reveal Email/Phone |
3 | VP Global Education | Reveal Email/Phone |
4 | VP Sales | Reveal Email/Phone |
5 | VICE PRESIDENT, GENERAL COUNSEL, AND CORPORATE SECRETARY | Reveal Email/Phone |
6 | Sr. Director Human Resources | Reveal Email/Phone |
7 | Director Sales | Reveal Email/Phone |
8 | Information Technology Manager | Reveal Email/Phone |
9 | Sr. Warehouse & Production Manager | Reveal Email/Phone |
10 | Senior Marketing Manager | Reveal Email/Phone |
Jan Marini Skin Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 29 | -19% | N/A | N/A |
#2 | $35M | 142 | 7% | N/A | N/A |
#3 | $3.5M | 18 | -22% | N/A | N/A |
#4 | $15M | 605 | 7% | N/A | N/A |
#5 | $7.5M | 157 | 22% | N/A | N/A |
#6 | N/A | 67 | 60% | N/A | N/A |
#7 | $3.5M | 37 | -3% | N/A | N/A |
#8 | $7.5M | 42 | 27% | N/A | N/A |
#9 | $15M | 545 | -21% | N/A | N/A |
#10 | N/A | 29 | 0% | N/A | N/A |
What Is Jan Marini Skin Research?
Jan Marini Skin Research (JMSR) is a leading manufacturer of medically validated skin care and aesthetic products for the professional marketplace. This market principally includes Physicians, PAs, RN's and licensed estheticians. JMSR employs a direct sales organization in the United States and its products are sold by independent distributors throughout the world. Founded in 1994, JMSR is known for creating breakthrough product solutions and dramatic technological advancements. JMSR pioneered the use of Glycolic Acid in skin care and developed the first stable topical Vitamin C product (Ascorbyl Palmitate) years ahead of the commercial marketplace. In 2005, JMSR became the first company to market a cosmetic eyelash enhancement conditioner that has since revolutionized the industry and created an increasingly popular beauty category. Over the years, the company has established a portfolio of proprietary formulas that reflect its ongoing commitment to be the preeminent developer of skin care products that produce measureable clinical results and benefits. Jan Marini, founder and Chairman of the Board of JMSR, has devoted more than three decades to research and development of the cutting-edge technologies used in our products. She has also formed associations with some of the world's leading physicians and research scientists. As a respected international skin care authority, Jan Marini continues to lead JMSR and the industry at large to new heights. Jan Marini has been a popular keynote speaker at many International Tradeshows and Medical Conferences principally focused on technological innovation in skin care. In addition, Jan has appeared frequently as a featured industry expert on television, radio and in other media.
keywords:Real EstateN/A
Total Funding
220
Number of Employees
$15M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Jan Marini Skin Research News
According to the report by Allied Market Research, titled, ... Glo Skin Beauty Bioelements, Jan Marini Skin Research Inc., Unilever plc.,...
... 2028 Research Report And Forecast Analysis Trends, Analysis Revision Skincare, Peter Thomas Roth, Jan Marini Skin Research, Eminence Organic Skin Care.
... Procter & Gamble Co., Jan Marini Skin Research L'Or al S.A., ... ZO Skin Health Inc., Merz Pharma, Obagi Cosmeceuticals LLC.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $43.6M | 220 | N/A | N/A |
#2 | $24.2M | 220 | 5% | N/A |
#3 | $42.1M | 220 | 51% | N/A |
#4 | $62.3M | 223 | 2% | N/A |
#5 | $35.9M | 225 | N/A | N/A |